Stock listing
NASDAQ:BDSI BioDelivery Sciences International Inc Stock
Follow BioDelivery Sciences International Inc into a list and get an email when it puts out news.
Last close · NASDAQ:BDSI
$5.59 USD
Close on Mar 22, 2022 · No longer trades
- Lowest – highest close
- $0.78 – $18.15 USDSince Jul 25, 2002 · lowest Dec 28, 2011 · highest Sep 12, 2014
Delisted NASDAQ:BDSI no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:BDSI
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
BioDelivery Sciences International Inc on 6ix
- Calls
- 4 calls with a replay · 4 with a transcript · latest Nov 3, 2021
- Decks
- 1 deck · latest Apr 3, 2009
Events
| Call | When | Status |
|---|---|---|
| BioDelivery Sciences International (BDSI) Q3 2021 Earnings Call | Wed, Nov 03, 2021 · 8:30 AM ET | Replay |
| BioDelivery Sciences International (BDSI) Q1 2021 Earnings Call | Thu, May 06, 2021 · 8:30 AM ET | Replay |
| BioDelivery Sciences International (BDSI) Q4 2020 Earnings Call | Wed, Mar 10, 2021 · 8:30 AM ET | Replay |
| BioDelivery Sciences International (BDSI) Q3 2020 Earnings Call | Thu, Nov 05, 2020 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (April 2009) | Investor deck | 36 slides | Apr 3, 2009 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mary Theresa Coelho Other companies: Hookipa Pharma Inc (EVP and CFO, Director · Since at least Apr 3, 2023); Inotiv, Inc. (Director · Oct 16, 2023 – Apr 1, 2025 · Past); Gamida Cell Ltd (Chief Financial Officer · May 22, 2023 – Jun 12, 2023 · Past); CinCor Pharma Inc (EVP CFO & Chief BD Officer · Jan 6, 2022 – Jan 11, 2022 · Past); GridAI Technologies Corp. (Director · Aug 11, 2021 – Jan 2, 2024 · Past); Balchem Corporation (Chief Financial Officer · Oct 23, 2017 – Oct 26, 2018 · Past) | See Remarks · Jan 15, 2019 – Jan 29, 2021 · Past |
| Peter Greenleaf Other companies: Pelthos Therapeutics Inc. (Director · Since at least Jul 1, 2025); Aurinia Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Jan 1, 2021); Antares Pharma Inc (Director · Dec 12, 2018 – May 24, 2022 · Past); Kiora Pharmaceuticals, Inc. (Director · Jul 10, 2018 – Feb 1, 2019 · Past); Avalo Therapeutics, Inc. (Director · Mar 27, 2018 – Aug 7, 2019 · Past); Sucampo Pharmaceuticals Inc (Chief Executive Officer · Sep 30, 2017 – Feb 13, 2018 · Past) | Director · May 21, 2018 – Mar 22, 2022 · Past |
| Jeffrey Bailey Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Aug 18, 2023); Rein Therapeutics, Inc. (Director · Mar 15, 2018 – Jun 17, 2022 · Past); Lantheus Holdings, Inc. (CEO and President, Director · Jun 24, 2015 – Aug 31, 2015 · Past); Landauer Inc (Director · Apr 17, 2015 – Oct 19, 2017 · Past); King Pharmaceuticals Inc (Chief Commercial Officer · Aug 30, 2010 – Mar 1, 2011 · Past) | Chief Executive Officer, Director · Mar 9, 2020 – Mar 22, 2022 · Past |
| Todd Davis Other companies: Palvella Therapeutics, Inc. (Director · Since at least Dec 13, 2024); Pelthos Therapeutics Inc. (Director · Since at least Feb 15, 2024); Ligand Pharmaceuticals Incorporated (Chief Executive Officer · Since at least May 25, 2010); Vaxart, Inc. (Director · Oct 25, 2019 – Aug 4, 2022 · Past) | Director · May 21, 2018 – Mar 22, 2022 · Past |
| W. Mark Watson Other companies: Vaxart, Inc. (Lead Independent Director · Since at least Aug 4, 2022); Sykes Enterprises Incorporated (Director · May 22, 2018 – Aug 27, 2021 · Past); Inhibitor Therapeutics Inc. (Director · Aug 14, 2015 – Dec 22, 2020 · Past) | Director · Dec 8, 2016 – Mar 22, 2022 · Past |
| Charles Bramlage Other companies: Eiger Biopharmaceuticals Inc (Director · Mar 22, 2016 – Apr 12, 2017 · Past); Valeant Pharmaceuticals International Inc (President, Europe · Oct 30, 2007 – Oct 30, 2007 · Past) | Director · Jul 17, 2014 – Aug 14, 2017 · Past |
| Timothy Tyson Other companies: Syros Pharmaceuticals, Inc. (Director · Sep 16, 2022 – Jun 5, 2024 · Past); Tyme Technologies Inc (Director · Jul 27, 2017 – Sep 16, 2022 · Past) | Director · Oct 4, 2016 – Aug 14, 2017 · Past |
| Francis E Odonnell Jr Other companies: Inhibitor Therapeutics Inc. (Chief Executive Officer, Director · Since at least Jun 6, 2016) | Director · Jun 15, 2016 – May 11, 2020 · Past |
| John Golubieski Other companies: Axsome Therapeutics, Inc. (Chief Financial Officer · Aug 4, 2017 – Aug 4, 2017 · Past) | See Remarks · Oct 25, 2021 – Mar 22, 2022 · Past |
| Scott M. Plesha Other companies: Pelthos Therapeutics Inc. (CEO and President, Director · Since at least Jul 2, 2025) | See Remarks · Jan 27, 2021 – Mar 22, 2022 · Past |
All 13 people
| Person | Seat |
|---|---|
| Andrew L Finn | Executive Vice President · Dec 31, 2005 – Jun 15, 2015 · Past |
| Benny Ward | EVP of Busi. & Strategic Dev. · Sep 7, 2010 – Mar 16, 2012 · Past |
| Thomas D'Alonzo | Director · Apr 23, 2013 – Aug 14, 2017 · Past |
Log in to ask 6ix AI your own questions about BioDelivery Sciences International Inc.